Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear

[1]  L. Chhabra,et al.  Transdermal innovations in diabetes management. , 2015, Current diabetes reviews.

[2]  S. Edelman,et al.  Inhaled insulin: a breath of fresh air? A review of inhaled insulin. , 2014, Clinical therapeutics.

[3]  Michael S. Roberts,et al.  Microneedle Enhanced Delivery of Cosmeceutically Relevant Peptides in Human Skin , 2014, PloS one.

[4]  Mark R Prausnitz,et al.  Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes , 2013, Pediatric diabetes.

[5]  L. Heinemann,et al.  Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time. , 2013, Diabetes technology & therapeutics.

[6]  B. Sarmento,et al.  Oral Insulin Delivery: How Far are We? , 2013, Journal of diabetes science and technology.

[7]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[8]  W. Tamborlane,et al.  Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device , 2012, Pediatric diabetes.

[9]  P. D. Home,et al.  The pharmacokinetics and pharmacodynamics of rapid‐acting insulin analogues and their clinical consequences , 2012, Diabetes, obesity & metabolism.

[10]  Ronald J. Pettis,et al.  Pharmacokinetics and Postprandial Glycemic Excursions following Insulin Lispro Delivered by Intradermal Microneedle or Subcutaneous Infusion , 2012, Journal of diabetes science and technology.

[11]  L. Heinemann,et al.  Ultrafast-Acting Insulins: State of the Art , 2012, Journal of diabetes science and technology.

[12]  Roderike Pohl,et al.  A Review of a Family of Ultra-Rapid-Acting Insulins: Formulation Development , 2012, Journal of diabetes science and technology.

[13]  L. Heinemann,et al.  Insulin Infusion Set: The Achilles Heel of Continuous Subcutaneous Insulin Infusion , 2012, Journal of diabetes science and technology.

[14]  R. Pettis,et al.  Microneedle delivery: clinical studies and emerging medical applications. , 2012, Therapeutic delivery.

[15]  D. Dunger,et al.  Closed-loop insulin delivery for treatment of type 1 diabetes , 2011, BMC medicine.

[16]  C. Cobelli,et al.  Artificial Pancreas: Past, Present, Future , 2011, Diabetes.

[17]  Mark R Prausnitz,et al.  Infusion pressure and pain during microneedle injection into skin of human subjects. , 2011, Biomaterials.

[18]  Lutz Heinemann,et al.  Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. , 2011, Diabetes technology & therapeutics.

[19]  Lutz Heinemann,et al.  Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. , 2011, Diabetes technology & therapeutics.

[20]  Mark R Prausnitz,et al.  Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. , 2011, Diabetes technology & therapeutics.

[21]  Andreas Pfützner,et al.  Pilot Study for Assessment of Optimal Frequency for Changing Catheters in Insulin Pump Therapy—Trouble Starts on Day 3 , 2010, Journal of diabetes science and technology.

[22]  Michael A. Gibney,et al.  Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations , 2010, Current medical research and opinion.

[23]  R. Donnelly,et al.  Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety , 2010, Drug delivery.

[24]  C. L. Yau,et al.  Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion. , 2010, Journal of diabetes and its complications.

[25]  B. Stallknecht,et al.  Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. , 2009, Diabetes technology & therapeutics.

[26]  Toke Folke Christensen,et al.  Sources of Glycemic Variability—What Type of Technology is Needed? , 2009, Journal of diabetes science and technology.

[27]  M. Prausnitz,et al.  Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. , 2009, Diabetes technology & therapeutics.

[28]  G. Steil,et al.  Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth With Type 1 Diabetes Receiving Insulin Pump Therapy , 2009, Diabetes Care.

[29]  Mark R. Prausnitz,et al.  Effect of Microneedle Design on Pain in Human Volunteers , 2008, The Clinical journal of pain.

[30]  P. Laurent,et al.  Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. , 2007, Vaccine.

[31]  Guido Freckmann,et al.  Continuous Glucose Profiles in Healthy Subjects under Everyday Life Conditions and after Different Meals , 2007, Journal of diabetes science and technology.

[32]  A. Laurent,et al.  Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. , 2007, Vaccine.

[33]  A. Cherrington.  The role of hepatic insulin receptors in the regulation of glucose production. , 2005, The Journal of clinical investigation.

[34]  G. Bolli,et al.  Insulin analogues and their potential in the management of diabetes mellitus , 1999, Diabetologia.

[35]  H. Arnqvist,et al.  No Pharmacokinetic Effect of Retaining the Infusion Site up to Four Days During Continuous Subcutaneous Insulin Infusion Therapy , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[36]  A. Mitra,et al.  Analysis of the absorption kinetics of macromolecules following intradermal and subcutaneous administration. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[37]  G. Babiera,et al.  Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents. , 2013, Biomedical optics express.

[38]  Scott A. Kaestner,et al.  Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs , 2010, Pharmaceutical Research.

[39]  R. Henkin.  Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action. , 2010, Nutrition.

[40]  Lutz Heinemann,et al.  Variability of insulin absorption and insulin action. , 2002, Diabetes technology & therapeutics.

[41]  R. Wredling,et al.  Insulin absorption is faster when keeping the infusion site in use for three days during continuous subcutaneous insulin infusion. , 1991, Diabetes research and clinical practice.